// OVERVIEW
Pharma strategic investor participating in NewLimit's fundraise.
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·Axios Pro Rata·OCTOBER 2, 2026
“Abogen has raised over $1 billion from firms like SoftBank, 5Y Capital, Mirae Asset Management, Lilly Asia Ventures, Loyal Valley Capital, Hillhouse, PICC Capital, Qiming Ventures, and SDIC Venture Capital.”
02
funding·StrictlyVC·JUNE 3, 2026
“NewLimit raised $435M at a $3.1B valuation for anti-aging research, led by Founders Fund with participation from Kleiner Perkins, Thrive Capital, and notably Eli Lilly Ventures.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.